CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čas. Lék. čes., 2007, 146, pp. 922–924.
 
Treatment Options in Sarcoidosis 
Slováková A., Votava V., Homolka J. 

I. klinika tuberkulózy a respiračních nemocí 1. LF UK a VFN, Praha
 


Summary:

       When to start the treatment of sarcoidosis and what are the optimal treatment methods? The curative of the first choice are glucocorticoids used in indicated cases in general administration, as inhalation therapy or locally in the skin manifestations. Frequently used are also immunosuppressives, cytostatics and antimalarics. The newest trend in the treatment of this multi-organ granulomatose disease of unknown origin is the use of TNF inhibitors– pentoxifyllin, infliximab, adalimumab, leflunomid, thalidomid.

        Key words: sarcoidosis, glucocorticoid, TNFα inhibitors, pentoxifyllin, infliximab, adalimumab, leflunomid, thalidomide
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER